Precision BioSciences (FRA:PBS0) Change In Payables And Accrued Expense : €-0.04 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Change In Payables And Accrued Expense?

Precision BioSciences's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was €-1.93 Mil. It means Precision BioSciences's Accounts Payable & Accrued Expense declined by €1.93 Mil from Dec. 2023 to Mar. 2024 .

Precision BioSciences's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €1.38 Mil. It means Precision BioSciences's Accounts Payable & Accrued Expense increased by €1.38 Mil from Dec. 2022 to Dec. 2023 .

Precision BioSciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Precision BioSciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Change In Payables And Accrued Expense Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.60

-1.20

0.77

0.14

1.38

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.52	0.11	-0.05	1.84	-1.93

Precision BioSciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

Precision BioSciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines